Research paperMimtags: The use of phage display technology to produce novel protein-specific probes
Introduction
Protein-specific probes used for epitope mapping and protein-tagging studies have been the focal point of research during recent years employing various methods of detection of proteins, such as antibodies and labelled proteins. Currently, protein analysis consists of immunoassay techniques such as ELISA, polyacrylamide gel electrophoresis and related blotting techniques that use antibodies for detection and interactions with antigens (Westermeier and Marouga, 2005). The advent of monoclonal antibodies with the development of hybridoma technology by Kohler and Milstein in 1975 was another remarkable milestone, which has revolutionised the way we conduct research today (Borrebaeck, 2000, Chames et al., 2009, Kennett, 1979, Kohler and Milstein, 1975). Monoclonal antibodies are generally specific to the target antigen and are often used for epitope mapping of proteins for exploring the human proteome for diagnostics and therapeutic purposes (Rockberg et al., 2008). The epitope region can either be linear or conformational in their structure and the amino acid sequence can be continuous or discontinuous (Siddiqui, 2010). The ability of monoclonal antibodies to detect a single antigenic determinant (epitope) has earned it a major advantage over the use of polyclonal antisera. However, there are disadvantages of using antibodies where precise recognition of epitopes is seldom accurate (Rowley et al., 2004) and there are limitations and disadvantages with these techniques (Attarwala, 2010). The hybridoma technology involves many phases from the fusion of the primed B cells with myeloma cell line to the large-scale production of monoclonal antibodies from these highly selective hybrid cell lines (Falkenberg, 1998, Kohler and Milstein, 1975). For researchers working in the field, the use of this available in vitro technique is often problematic and has found to be very labour intensive and expensive (Falkenberg, 1998). Animal ethics is a major concern when it comes to development of monoclonal antibodies, which causes unnecessary suffering of animals (Falkenberg, 1998, Festing and Wilkinson, 2007). Another disadvantage of larger protein based probes, such as biotin binding proteins, is the size of these antibodies that are tagged with a detectable label. Larger probes present a challenge of inefficiently penetrating the conformational structures of target proteins as opposed to short peptides. For example, a large protein such as an antibody may interact with random functional groups on a single protein to the exclusion of thousands of other competing cytoplasmic proteins, nucleic proteins, carbohydrates and small molecules (Chen and Ting, 2005). It is therefore imperative to find new techniques that are particularly important for quantitative proteomics, less tedious and cost-effective.
A more contemporary pattern of research has brought short peptide sequences under the spotlight as target specific probes for in vitro and in vivo analysis of protein ligands such as transmembrane proteins. This type of epitope tagging has led to very successful epitope mapping of target antigens. The methodology has been used for protein localization, immunoprecipitation, and protein–protein interaction (Hernan et al., 2000). Briefly, an epitope is a sequence of amino acids in any structure that is recognised by an antibody. A single protein may carry multiple epitopes that can be recognised by antibodies. A mimotope (peptides mimicking epitopes) is a structure that mimics the structure of an epitope. Due to this structural similarity, a mimotope can elicit the same antibody response as an epitope via the paratope region of the antibody. Two decades ago it was realised that using peptide phage libraries, mimotopes could be isolated which mimic the epitope on a given protein. Using this technique, the 3-dimensional structure of the epitope can be determined along with the critical residues that make up the epitope (Xu et al., 2004). Hence, in this case the mimotope acts as a probe against the desired epitope on a protein or antibody as a therapeutic agonist or antagonist.
A new term introduced in this paper is ‘Mimtags’ which are the same short sequences of amino acids that play a critical role in the advancement of phage technology from a very different perspective. These short sequences of peptides are a part of fused proteins on the surfaces of phage used in phage display libraries. These mimotopes (Knittelfelder et al., 2009) that can be tagged (mimtags) on to protein sequence can effectively identify the epitope region of a target antigen as protein-specific probes. Hence, the term “mimtag” will now be used throughout the entire body of this paper replacing the term peptide mimotope.
The technique has been used in various studies to prove its effectiveness. A recent study conducted by our NeuroAllergy Research Laboratory (NARL) has shown remarkable results (Ahmed et al., 2011, Ahmed et al., 2012, Ahmed et al., 2013). In our study, random peptide library on M13 phage was used to screen IL-4R and IL-13. An affinity selection in this way allows the identification of mimtags that bind to the cytokine and its receptor, and hence, will most likely target epitopes more effectively due to the small size and nature of the mimtag (12-mer peptide). The mimtag also has the ability to conform to 3-Dimensional configuration, increasing its binding efficiency (Bredehorst and David, 2001). The bound peptide was sequenced and synthesised for further characterisation by immunoassay techniques. The study shows the potential use of biotinylated peptide mimtags as examples and their advantage over complex antigens and antibodies being applied as novel protein specific probes.
Section snippets
Materials and methods
To reveal the methodology involved in the isolation and characterisation of novel mimtags, we have divided the methods between two mimtags denoted N1 as an antagonist for IL-4R and P9 for IL-13. Phage display along with ELISA immunoassay (for the N1 mimtag) and dot-blot assay (for the P9 mimtag) were used for immunological characterisation of mimtags. Our research group identified both mimtags using phage display technology and inhibited the proteins from binding to their corresponding proteins
Results
Peptide phage clones from 12-mer libraries were analysed by taking 3 random peptides from the 10 individual phage clones isolated from the 5th round of biopanning. Each clone was diluted, plated, amplified, sequenced and tested for reactivity with the target protein IL-4R using ELISA immunoassays and in the case of IL-13, a dot-blot (Fig. 1). A different technique to the different proteins has been used to show a range of method applications.
Discussion
The aims of this work were, to isolate phage-displayed mimtags against IL-4R and IL-13, to investigate the ability of mimtags to bind target proteins and act as protein-specific probes. High-quality mimtags were isolated during the study, which recognised IL-4R and IL-13 specifically.
Conclusion
We have successfully demonstrated that both examples of IL-4R and IL-13 as target proteins illustrate the importance of using mimtags in the field of proteomics as protein-specific probes along with many other examples (Knittelfelder et al., 2009, Murata et al., 2005, Pacios et al., 2008). Mimtags labelled with biotin can be used to detect and probe specific epitopes on proteins, which is less time-consuming, more efficient and versatile then antibodies. Hence, introducing this new method of
Acknowledgments
This study was supported by School of Life and Environmental Sciences, Molecular and Medical Research (MMR) Strategic Research Centre (SRC) and Centre for Chemistry and Biotechnology (CCB), Deakin University. Nayyar Ahmed was financially supported with a Deakin University PhD Scholarship.
References (52)
- et al.
Identification and characterisation of a novel cytokine IL-13 antagonist for allergy treatment
Intern. Med. J.
(2013) Antibodies in diagnostics—from immunoassays to protein chips
Immunol. Today
(2000)- et al.
What establishes a protein as an allergen?
J. Chromatogr. B Biomed. Sci. Appl.
(2001) - et al.
Site-specific labeling of proteins with small molecules in live cells
Curr. Opin. Biotechnol.
(2005) Monoclonal antibody production: problems and solutions
Res. Immunol.
(1998)- et al.
Cross-reactive epitope mimics in a fragmented-genome phage display library derived from the rickettsia, Cowdria ruminantium
Immunotechnology
(1999) - et al.
Isolation and structure-functional characterization of phage display library-derived mimotopes of noxiustoxin, a neurotoxin of the scorpion Centruroides noxius Hoffmann
Mol. Immunol.
(2000) - et al.
Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library
J. Allergy Clin. Immunol.
(2004) - et al.
Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides
Gene
(1993) - et al.
Solution structure of human IL-13 and implication for receptor binding
J. Mol. Biol.
(2001)
Mimotope mapping as a complementary strategy to define allergen IgE-epitopes: peach Pru p 3 allergen as a model
Mol. Immunol.
Allergen mimotopes
Methods
Phage display for epitope determination: a paradigm for identifying receptor–ligand interactions
Biotechnol. Annu. Rev.
A guide to the perplexed on the specificity of antibodies
J. Histochem. Cytochem.
Structure of a high-affinity “mimotope” peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies
J. Mol. Biol.
The importance of characterization of FITC-labeled antibodies used in tissue cross-reactivity studies
Acta Histochem.
Mimotope of Leptospira from phage-displayed random peptide library is reactive with both monoclonal antibodies and patients' sera
Vet. Microbiol.
Fluorescent-labeled antibodies: balancing functionality and degree of labeling
Anal. Biochem.
Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry
Mol. Immunol.
Characterisation of a novel IL-4 receptor antagonist for allergy treatment
Allergy
Identification and characterization of a novel IL-4 receptor antagonist for allergy treatment
Intern. Med. J.
Role of antibodies in cancer targeting
J. Nat. Sci. Biol. Med.
Therapeutic antibodies: successes, limitations and hopes for the future
Br. J. Pharmacol.
Random peptide libraries: a source of specific protein binding molecules
Science
The ethics of animal research. Talking point on the use of animals in scientific research
EMBO Rep.
The use of phage-peptide libraries to define the epitope specificity of a mouse monoclonal anti-Der p 1 antibody representative of a major component of the human immunoglobulin E anti-Der p 1 response
Clin. Exp. Allergy
Cited by (3)
Prediction of epitope of Coxsackievirus A16
2019, Chinese Journal of BiologicalsIdentification and Characterization of a Novel IL-4 Receptor α Chain (IL-4Rα) Antagonist to Inhibit IL-4 Signalling
2015, Cellular Physiology and Biochemistry